Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Gut microbiome-derived phenyl sulfate contributes to albuminuria in diabetic kidney disease.

Kikuchi K, Saigusa D, Kanemitsu Y, Matsumoto Y, Thanai P, Suzuki N, Mise K, Yamaguchi H, Nakamura T, Asaji K, Mukawa C, Tsukamoto H, Sato T, Oikawa Y, Iwasaki T, Oe Y, Tsukimi T, Fukuda NN, Ho HJ, Nanto-Hara F, Ogura J, Saito R, Nagao S, Ohsaki Y, Shimada S, Suzuki T, Toyohara T, Mishima E, Shima H, Akiyama Y, Akiyama Y, Ichijo M, Matsuhashi T, Matsuo A, Ogata Y, Yang CC, Suzuki C, Breeggemann MC, Heymann J, Shimizu M, Ogawa S, Takahashi N, Suzuki T, Owada Y, Kure S, Mano N, Soga T, Wada T, Kopp JB, Fukuda S, Hozawa A, Yamamoto M, Ito S, Wada J, Tomioka Y, Abe T.

Nat Commun. 2019 Apr 23;10(1):1835. doi: 10.1038/s41467-019-09735-4.

2.

Protease-activated receptor 2 protects against VEGF inhibitor-induced glomerular endothelial and podocyte injury.

Oe Y, Fushima T, Sato E, Sekimoto A, Kisu K, Sato H, Sugawara J, Ito S, Takahashi N.

Sci Rep. 2019 Feb 27;9(1):2986. doi: 10.1038/s41598-019-39914-8.

3.

Nicotinamide alleviates kidney injury and pregnancy outcomes in lupus-prone MRL/lpr mice treated with lipopolysaccharide.

Imaruoka K, Oe Y, Fushima T, Sato E, Sekimoto A, Sato H, Sugawara J, Ito S, Takahashi N.

Biochem Biophys Res Commun. 2019 Mar 19;510(4):587-593. doi: 10.1016/j.bbrc.2019.01.110. Epub 2019 Feb 7.

PMID:
30739788
4.

Protease-activated receptor 2 exacerbates cisplatin-induced nephrotoxicity.

Watanabe M, Oe Y, Sato E, Sekimoto A, Sato H, Ito S, Takahashi N.

Am J Physiol Renal Physiol. 2019 Apr 1;316(4):F654-F659. doi: 10.1152/ajprenal.00489.2018. Epub 2019 Jan 23.

PMID:
30672316
5.

Vitamin B3 Nicotinamide: A Promising Candidate for Treating Preeclampsia and Improving Fetal Growth.

Takahashi N, Li F, Fushima T, Oyanagi G, Sato E, Oe Y, Sekimoto A, Saigusa D, Sato H, Ito S.

Tohoku J Exp Med. 2018 Mar;244(3):243-248. doi: 10.1620/tjem.244.243. Review.

6.

Hepatic dysfunction and thrombocytopenia induced by excess sFlt1 in mice lacking endothelial nitric oxide synthase.

Oe Y, Ko M, Fushima T, Sato E, Karumanchi SA, Sato H, Sugawara J, Ito S, Takahashi N.

Sci Rep. 2018 Jan 8;8(1):102. doi: 10.1038/s41598-017-18260-7.

7.

Impact of the Oral Adsorbent AST-120 on Organ-Specific Accumulation of Uremic Toxins: LC-MS/MS and MS Imaging Techniques.

Sato E, Saigusa D, Mishima E, Uchida T, Miura D, Morikawa-Ichinose T, Kisu K, Sekimoto A, Saito R, Oe Y, Matsumoto Y, Tomioka Y, Mori T, Takahashi N, Sato H, Abe T, Niwa T, Ito S.

Toxins (Basel). 2017 Dec 28;10(1). pii: E19. doi: 10.3390/toxins10010019.

8.

Protease-activated receptor 2 exacerbates adenine-induced renal tubulointerstitial injury in mice.

Hayashi S, Oe Y, Fushima T, Sato E, Sato H, Ito S, Takahashi N.

Biochem Biophys Res Commun. 2017 Jan 29;483(1):547-552. doi: 10.1016/j.bbrc.2016.12.108. Epub 2016 Dec 23.

PMID:
28025140
9.

Nicotinamide ameliorates a preeclampsia-like condition in mice with reduced uterine perfusion pressure.

Fushima T, Sekimoto A, Oe Y, Sato E, Ito S, Sato H, Takahashi N.

Am J Physiol Renal Physiol. 2017 Feb 1;312(2):F366-F372. doi: 10.1152/ajprenal.00501.2016. Epub 2016 Dec 7.

10.

Metabolic alterations by indoxyl sulfate in skeletal muscle induce uremic sarcopenia in chronic kidney disease.

Sato E, Mori T, Mishima E, Suzuki A, Sugawara S, Kurasawa N, Saigusa D, Miura D, Morikawa-Ichinose T, Saito R, Oba-Yabana I, Oe Y, Kisu K, Naganuma E, Koizumi K, Mokudai T, Niwano Y, Kudo T, Suzuki C, Takahashi N, Sato H, Abe T, Niwa T, Ito S.

Sci Rep. 2016 Nov 10;6:36618. doi: 10.1038/srep36618.

11.

Nicotinamide benefits both mothers and pups in two contrasting mouse models of preeclampsia.

Li F, Fushima T, Oyanagi G, Townley-Tilson HW, Sato E, Nakada H, Oe Y, Hagaman JR, Wilder J, Li M, Sekimoto A, Saigusa D, Sato H, Ito S, Jennette JC, Maeda N, Karumanchi SA, Smithies O, Takahashi N.

Proc Natl Acad Sci U S A. 2016 Nov 22;113(47):13450-13455. Epub 2016 Nov 7.

12.

Coagulation Factor Xa and Protease-Activated Receptor 2 as Novel Therapeutic Targets for Diabetic Nephropathy.

Oe Y, Hayashi S, Fushima T, Sato E, Kisu K, Sato H, Ito S, Takahashi N.

Arterioscler Thromb Vasc Biol. 2016 Aug;36(8):1525-33. doi: 10.1161/ATVBAHA.116.307883. Epub 2016 Jun 9.

PMID:
27283743
13.

Reduced Uterine Perfusion Pressure (RUPP) Model of Preeclampsia in Mice.

Fushima T, Sekimoto A, Minato T, Ito T, Oe Y, Kisu K, Sato E, Funamoto K, Hayase T, Kimura Y, Ito S, Sato H, Takahashi N.

PLoS One. 2016 May 17;11(5):e0155426. doi: 10.1371/journal.pone.0155426. eCollection 2016.

14.

Effects of cyclophosphamide on the prognosis of Japanese patients with renal vasculitis associated with anti-neutrophil cytoplasmic antibody-positive microscopic polyangiitis.

Iwabuchi M, Nakaya I, Tsuchiya Y, Shibagaki Y, Yamaguchi T, Fukuhara S, Oe Y, Sakuma T, Sato T, Taguma Y, Soma J.

Clin Exp Nephrol. 2016 Oct;20(5):712-719. Epub 2015 Nov 20.

PMID:
26590052
15.

Proliferative glomerulonephritis with monoclonal IgM-κ deposits in chronic lymphocytic leukemia/small lymphocytic leukemia: case report and review of the literature.

Oe Y, Joh K, Sato M, Taguma Y, Onishi Y, Nakayama K, Sato T.

CEN Case Rep. 2013 Nov;2(2):222-227. doi: 10.1007/s13730-013-0068-z. Epub 2013 Mar 1.

16.

Heavy chain deposition disease: an overview.

Oe Y, Soma J, Sato H, Ito S.

Clin Exp Nephrol. 2013 Dec;17(6):771-8. doi: 10.1007/s10157-013-0812-x. Epub 2013 May 8. Review.

PMID:
23652830
17.

κ I light chain AL amyloidosis presenting with rapidly progressive renal and hepatic failure with unusual renal amyloid distribution.

Oe Y, Nakaya I, Yahata M, Murata O, Yaegashi H, Sakuma T, Sato H, Liepnieks JJ, Benson MD, Soma J.

Clin Nephrol. 2012 Jan;77(1):66-70.

PMID:
22185971
18.

A case of γ1-heavy chain deposition disease successfully treated with melphalan and prednisolone therapy.

Oe Y, Nakaya I, Yahata M, Sakuma T, Sato H, Soma J.

Intern Med. 2010;49(14):1411-5. Epub 2010 Jul 15. Review.

Supplemental Content

Loading ...
Support Center